Objectives This longitudinal study aimed to examine the relationship between return-to-work self-efficacy (RTW-SE), anxiety, and depression in patients with renal cancer. Methods A total of 282 patients with renal cancer from Sun Yat-sen University Cancer Center were recruited between April and December 2022. Patients were assessed at one month (T1), three months (T2), and six months (T3) after surgery using a general information questionnaire, Return-to-Work Self-Efficacy Scale, Generalized Anxiety Disorder Scale (GAD- 7), and Patient Health Questionnaire (PHQ- 9). Results RTW-SE progressively increased over time, while anxiety and depression scores showed a decreasing trend. Pearson’s correlation analysis revealed a significant negative association between RTW-SE and both anxiety and depression at all three-time points. Cross-lagged analysis demonstrated that RTW-SE at T1 significantly predicted depression at T2 (β = - 0.066, P < 0.001), whereas RTW-SE at T2 significantly predicted both anxiety (β = - 0.177, P < 0.001) and depression (β = - 0.077, P < 0.001) at T3. Conclusion Higher RTW-SE scores were associated with lower levels of post-surgery anxiety and depression. These findings highlight the importance of systematic RTW-SE assessments and early interventions to enhance work reintegration and psychological well-being. Incorporating RTW-SE monitoring into postoperative care plans may help to identify high-risk patients and facilitate timely psychological and vocational support.
Breast cancer is one of the common malignant tumors, and liquid biopsy has become a hot spot for clinical testing. To clarify the detection effect of liquid biopsy in breast cancer, we collected peripheral blood of HER2‐positive (human epidermal growth factor receptor 2‐positive) patients. Circulating tumor cells (CTCs) were isolated and analyzed. HER2 expression on CTCs was detected. The results showed that in the 198 HER2‐positive samples, the CTC detection rate was 79.8% (158/198), and the mean number of CTCs was 21, ranging from 1 to 63/7.5 mL peripheral blood. Only 41.1% (65/158) of patients had histology and CTC HER2 status consistent with the remaining 58.9% (93/158) of patients, although their histological HER2 was positive, and CTC HER2 was negative. Our study confirmed the value of CTC HER2 real‐time status testing in HER2‐positive breast cancer patients. The inconsistency in HER2 status between CTCs and histology may be related to the time interval between CTCs and histological HER2 detection, suggesting that real‐time HER2 detection is necessary for histological HER2‐positive patients.
Background: Testicular cancer usually occurs in young adult men between the ages of 20 and 40 years, which largely coincides with the age of men’s reproductive intentions. However, a serious side effect of testicular cancer therapy could reduce the fertility of patients. Purpose: To explore the experience of fertility concerns in patients with testicular cancer. Methods: A phenomenological research was conducted on 12 patients with testicular cancer. Data collection was from May 2023 to August 2023, and Colaizzi analysis method was used to analyze the data. Results: Four themes were found: (1) multiple worries and negative emotions, (2) fertility decision-making faces many challenges, (3) self-coping strategies for facing fertility concerns, (4) unmet supportive care needs. Conclusion: Medical staff should pay attention to the fertility needs of patients with testicular cancer and provide relevant interventions and support to reduce their fertility concerns.